Sensitivity of the Montreal Cognitive Assessment in screening for cognitive impairment in patients with newly diagnosed high-grade glioma.
Fiche publication
Date publication
mai 2020
Journal
Journal of neuro-oncology
Auteurs
Membres identifiés du Cancéropôle Est :
Pr NOEL Georges
Tous les auteurs :
Ribeiro M, Durand T, Roussel M, Feuvret L, Jacob J, Psimaras D, Noel G, Keller A, Bompaire F, Hoang-Xuan K, Bernier MO, Godefroy O, Ricard D
Lien Pubmed
Résumé
Cognitive impairment is frequent in patients with high-grade glioma and requires cognitive follow-up. Cognitive screening tools such as the Montreal Cognitive Assessment (MoCA) have been used to assess cognition in these patients. Here we assessed the sensitivity of the MoCA in screening for cognitive impairment in a cohort of 156 patients with newly-diagnosed high-grade glioma, after surgery and before radiochemotherapy.
Mots clés
Cognitive assessment, Cognitive deficits, Cognitive screening, High-grade glioma, Neuropsychology
Référence
J. Neurooncol.. 2020 May 15;: